VDR and breast carcinoma: In addition, VDR activation, with vitamin D or the synthetic analogue EB1089, could re-sensitize an antiestrogen resistant MCF7 breast cancer cell line to tamoxifen treatment and reduce the incidence of ER-positive mammary tumors in a preclinical model (190).